rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    PLUR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Pluri CEO Letter: Turning Our Cell Technology and Experience into Commercial Opportunity

      Pluri is translating more than two decades of cell-technology, manufacturing and clinical experience into a focused commercial strategyRegenerative medicine and the U.S. market are central to this next phase, supported by ZEO, CellaV and PluriCDMOClinical progress, strategic partnerships and greater financial alignment provide multiple avenues to unlock value across Pluri’s asset base HAIFA, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq and TASE: PLUR) (“Pluri” or the “Company”) t

      Nov 16Yahoo FinancePLUR
      Pluri: Fiscal Q1 Earnings Snapshot
      Nov 12Yahoo FinancePLUR
      Pluri Adds ISO 9001 and ISO 13485 Certifications to Support PluriCDMO Commercial Expansion
      Nov 9Yahoo FinancePLUR
      Pluri Inc. enters partnership with ZEO ScientifiX and announces equity financing
      Oct 30Investing.comPLUR
      Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments

      English-language call at 8:30 a.m. Eastern Time and Hebrew-language call at 11:00 a.m. Israel Time on Thursday, October 29, 2026HAIFA, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq and TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company advancing cell-based solutions for health and longevity, will host an online investor conference via Zoom this coming Thursday, October 29, 2026, featuring Mr. Yaky Yanay, CEO and President of Pluri and Mr. Alejandro Weinstein, Chairman

      Oct 27Yahoo FinancePLUR
      Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine

      Partnership combines Pluri’s proprietary cell technology and clinical-development experience with ZEO’s biologics manufacturing expertise, established physician network, and sales, marketing, and educational infrastructure Pluri and ZEO Scientifix Strategic Agreement Ian Bothwell, CEO of ZEO, Bob Smoley, Founder of ZEO, Yaky Yanay CEO of Pluri Established U.S. commercial platform: ZEO contributes biologics manufacturing, scientific expertise, an existing product portfolio, physician relationship

      Oct 26Yahoo FinancePLUR
      Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company
      Oct 21Yahoo FinancePLUR
      Pluri: Fiscal Q4 Earnings Snapshot

      At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

      Sep 10Yahoo FinancePLUR
      Pluri Announces August 2026 Equity Financing Transaction

      Detailed price information for Pluri Inc (PLUR-Q) from The Globe and Mail including charting and trades.

      Aug 29The Globe and MailPLUR
      Pluri raises $3.3 million in registered direct offering
      Aug 27Investing.comPLUR
      Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

      HAIFA, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional ("3D") cell expansion platform across two principal business verticals: (i) Human Health & Longevity and (ii) FoodTech & Bio-Farming, today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor, for the purchase and sale of 2,228,940 Common Shares (or Common Sha

      Aug 27Yahoo FinancePLUR

      This is the newest page. Registered accounts read further back.